Insights

Strategic funding Sonnest has secured a $4M Series A, indicating early investor validation and potential readiness for partnership discussions with pharma, medical device manufacturers, or contract research organizations seeking novel imaging modalities.

Clinical value Electrast offers radiation-free, rapid myocardial perfusion assessment at the point of care, presenting a compelling value proposition for hospitals, cardiology clinics, and urgent care centers aiming to improve diagnostic speed and safety.

Targeted market As a pre-clinical stage medical imaging technology with a focus on the myocardium, there are opportunities to collaborate with cardiology device developers, ultrasound systems manufacturers, and imaging service providers seeking innovative contrast agents or activation-based imaging.

Strategic partnerships The Drexel-developed, physician-engineer collaboration and serial healthcare entrepreneur backing suggest a strong network for co-development, clinical trials, and pilot deployments with academic medical centers and early-adopter health systems.

Growth signals Revenue is currently under $1M, but ambitious fundraising and a scalable platform position Sonnest to pursue pilot programs, grant-funded studies, and measurable ROIs for potential customers evaluating cost-effective perfusion imaging alternatives.

Similar companies to Sonnest, Inc.

Sonnest, Inc. Tech Stack

Sonnest, Inc. uses 8 technology products and services including Cloudflare, RSS, WordPress, and more. Explore Sonnest, Inc.'s tech stack below.

  • Cloudflare
    Content Management System
  • RSS
    Content Management System
  • Content Management System
  • E-commerce
  • jQuery Migrate
    Javascript Libraries
  • Lightbox
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • PHP
    Programming Languages

Sonnest, Inc.'s Email Address Formats

Sonnest, Inc. uses at least 1 email format:
Sonnest, Inc. Email FormatsExamplePercentage
FLast@sonnest.comJDoe@sonnest.com
100%

Frequently Asked Questions

What is Sonnest, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Sonnest, Inc.'s official website is sonnest.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Sonnest, Inc. generate?

Minus sign iconPlus sign icon
As of September 2026, Sonnest, Inc.'s annual revenue is estimated to be <$1M.

What is Sonnest, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Sonnest, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Sonnest, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2026, Sonnest, Inc. has approximately 3 employees across 1 continents, including North America. Key team members include Chief Science Officer: S. W. Explore Sonnest, Inc.'s employee directory with LeadIQ.

What industry does Sonnest, Inc. belong to?

Minus sign iconPlus sign icon
Sonnest, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does Sonnest, Inc. use?

Minus sign iconPlus sign icon
Sonnest, Inc.'s tech stack includes Cloudflare, RSS, WordPress, Shopify, jQuery Migrate, Lightbox, Slider Revolution and PHP.

What is Sonnest, Inc.'s email format?

Minus sign iconPlus sign icon
Sonnest, Inc.'s email format typically follows the pattern of FLast@sonnest.com. Find more Sonnest, Inc. email formats with LeadIQ.

How much funding has Sonnest, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2026, Sonnest, Inc. has raised $4M in funding. The last funding round occurred on Feb 02, 2022.
Sonnest, Inc. logo

Sonnest, Inc.

Medical Equipment ManufacturingMaryland, United States2-10 Employees

Sonnest, Inc. is a medical equipment manufacturer focused on pre-clinical healthcare advances, developing Electrast™, an ultrasound imaging agent designed to circulate in its inactive form and become activated in the heart muscle to enable rapid, radiation-free assessment of myocardial perfusion at the point of care. The approach aims to provide clinicians with a cost-effective method to evaluate heart blood flow without exposing patients to ionizing radiation or toxic dyes. The company operates in the medical devices and imaging space, targeting providers and research teams involved in cardiac care and perfusion assessment. Based in Baltimore, Maryland, Sonnest was established by a collaboration of cardiologists and chemical engineers affiliated with Drexel University and related entrepreneurial teams. A notable recent development is the company’s oversubscribed Series A financing announced in mid-2021, reflecting progress in advancing its imaging technology toward clinical evaluation.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $4M

    Sonnest, Inc. has raised a total of $4M of funding over 2 rounds. Their latest funding round was raised on Feb 02, 2022 as a Convertible Note.

  • <$1M

    Sonnest, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.